In one paragraphArticle in Metabolites, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors at 4 institutions in 1 country.
Cristina GómezDivision of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, 4056 Basel, Switzerland.ORCID 0000-0001-8518-0095 Fadi JebbawiDivision of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, 4056 Basel, Switzerland.
Michael WeingartnerDivision of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, 4056 Basel, Switzerland.
Junhua WangDepartment of Infectious Diseases and Pathobiology, Vetsuisse Faculty, Institute of Parasitology, University of Bern, 3012 Berne, Switzerland.ORCID 0000-0002-6110-3711 Simon StücheliDivision of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, 4056 Basel, Switzerland.
Bruno StiegerDepartment of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland.
Bruno GottsteinDepartment of Infectious Diseases and Pathobiology, Vetsuisse Faculty, Institute of Parasitology, University of Bern, 3012 Berne, Switzerland.ORCID 0000-0003-0782-3723 Guido BeldiDepartment of Visceral Surgery and Medicine, University Hospital of Berne, 3010 Berne, Switzerland.ORCID 0000-0002-9914-3807 Britta Lundström-StadelmannDepartment of Infectious Diseases and Pathobiology, Vetsuisse Faculty, Institute of Parasitology, University of Bern, 3012 Berne, Switzerland.ORCID 0000-0003-2672-5766 Alex OdermattDivision of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, 4056 Basel, Switzerland.ORCID 0000-0002-6820-2712 University of Basel · CHUniversity of Bern · CHUniversity Hospital of Bern · CHUniversity of Zurich · CH
Funding
Swiss National Science Foundation 31003A-179400Swiss National Science Foundation 31003A-179439
6 · The paper itselfAbstract
Alveolar echinococcosis (AE) caused by
Indexed as
albendazolealveolar echinococcosisbile acidBSEPEchinococcus multilocularisLC-MS/MSNTCP
Identifiers
PMID34357336
PMCPMC8307106
OpenAlexW3178065093
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390